Growth stock are taking a breather, says Jim Cramer. So here's your game plan for next week.
Here are Thursday's top research calls, including upgrades for Box and Goodyear, and new coverage of Caesar's Entertainment and Idexx Labs.
Biogen's new spine disease drug outperformed expectations during its commercial debut.
Jim Cramer looks at how the French elections are smacking the U.S stock markets. Plus, he has the week-ahead game plan for oil and stocks.